Aleksei Tikhonov

Aleksei Tikhonov is an accomplished professional with extensive experience in translational research, assay development, and regulatory compliance in the field of oncology. Currently serving as a member of the CLSI Working Group and as an independent scientific consultant, Tikhonov contributes to the advancement of medical laboratory standards and advises biotech startups on biomarker strategies and regulatory documentation. Previous roles include postdoctoral research at Gustave Roussy, where Tikhonov led projects on immunotherapy, and technical writing at Lumiprobe Corporation, where Tikhonov drove product launches and marketing strategies. With a PhD in Molecular Biology and Oncology and publications in high-impact journals, Tikhonov combines scientific expertise with a strong commitment to improving clinical practices and patient outcomes.